Brief: Ampio Pharmaceuticals Regains Compliance With NYSE American Continued Listing Standards
27/12/2022 22:22
Dec 27 (Reuters) - Ampio Pharmaceuticals Inc AMPE.A :
* AMPIO PHARMACEUTICALS REGAINS COMPLIANCE WITH NYSE
AMERICAN
CONTINUED LISTING STANDARDS
Source: (https://bit.ly/3YQ5P5Q)
Further company coverage: AMPE.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ampio Pharmaceuticals
See all newsBrief: Ampio Announces Voluntary Delisting And SEC Deregistration
Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
Brief: Ampio Pharmaceuticals Announces Reverse Stock Split
Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank